Evaluation and Management of Presyncope
Diagnostic Approach
- ECG monitoring is the cornerstone of evaluation for presyncope, with additional testing guided by clinical features suggesting cardiac vs. non-cardiac causes, as recommended by the European Society of Cardiology 1
- Holter monitoring is indicated for very frequent presyncope (≥2 per week), according to the European Heart Journal guidelines 1, 2
- An external loop recorder should be considered if symptoms occur at intervals <4 weeks, as suggested by the European Society of Cardiology 1, 2
- An implantable loop recorder is recommended for recurrent unexplained episodes with high suspicion of arrhythmia, based on evidence from the European Heart Journal 2
- Risk stratification should consider factors such as age >60 years, abnormal cardiac examination, syncope during exertion, syncope without warning/prodrome, family history of sudden cardiac death, and abnormal ECG findings, including sinus bradycardia <40 beats/min, sinoatrial blocks or sinus pauses >3 seconds, Mobitz II 2nd or 3rd degree AV block, alternating bundle branch block, rapid paroxysmal SVT or VT, and pacemaker malfunction 2
- The American College of Cardiology identifies high-risk features requiring hospital admission, including older age (>60 years), abnormal cardiac examination, syncope during exertion, and family history of sudden cardiac death 3
- The American College of Cardiology identifies low-risk features for outpatient management, including younger age, normal ECG, no known cardiac disease, and presence of prodrome 3
Diagnostic Tests
The following diagnostic tests are recommended:
Test Recommendation Class 12-lead ECG All patients Class I, B-NR [3] Continuous ECG monitoring Hospitalized patients with suspected cardiac etiology Class I, B-NR [3, 4] Echocardiogram Structural heart disease suspected Class IIa, B-NR [3, 4] Electrophysiological study (EPS) Selected patients with suspected arrhythmic etiology Class IIa, B-NR [3, 4] Tilt-table testing Suspected vasovagal syncope, delayed orthostatic hypotension, and distinguishing convulsive syncope from epilepsy Class IIa, B-R [3, 4] Exercise stress testing Syncope occurs during exertion Class IIa, C-LD [4, 1, 5, 3] The following tests are not recommended without specific indications:
Test Recommendation MRI/CT of head Class III: No Benefit [3, 4] Carotid artery imaging Class III: No Benefit [3, 4] Routine EEG Class III: No Benefit [3, 4]
Management and Treatment
- Patient education on physical counterpressure maneuvers, including leg crossing with muscle tensing, squatting, arm tensing, and avoiding sudden position changes, is recommended by the American Heart Association 6
- Education on trigger avoidance, physical counterpressure maneuvers, and increased salt and fluid intake may be beneficial for patients with near syncope, as suggested by the American College of Cardiology 3
- Treatment should be directed at the underlying cardiac condition, and consideration of cardiology referral for high-risk patients, as recommended by the American College of Cardiology 5, 7
- Midodrine may be reasonable in recurrent cases without hypertension, and acute water ingestion, physical counterpressure maneuvers, and compression garments may provide temporary relief, as recommended by the American College of Cardiology 3
- Implantable cardiac monitor may be considered for patients with infrequent symptoms (>30 days between episodes) (Class IIa, B-R) 4, 3
Follow-up and Prognosis
- Cardiac causes of near syncope are associated with higher mortality (18-33% at 1 year) compared to non-cardiac causes (3-4%), making proper follow-up and diagnosis crucial for patient outcomes, as reported by the Annals of Emergency Medicine 8
- Intermediate-risk patients may be considered for structured emergency department observation protocol to reduce hospital admission rates, while low-risk patients may be managed in outpatient setting if no serious medical conditions are present, as suggested by the American College of Cardiology 4, 3
- Driving restrictions may be necessary after near syncope, with a 1-month restriction for syncope of undetermined etiology, 3-month restriction for cardiac cause after treatment, and no restriction for reflex syncope with clear trigger if trigger can be avoided, as recommended by the American College of Cardiology 7